Chronic lymphocytic leukaemia cells drive the global CD4+ T cell repertoire towards a regulatory phenotype and leads to the accumulation of CD4+ forkhead box P3+ T cells.

作者: KP Piper , M Karanth , Andrew McLarnon , E Kalk , Naeem Khan

DOI: 10.1111/J.1365-2249.2011.04466.X

关键词:

摘要: Advanced chronic lymphocytic leukaemia (CLL) is associated with profound immunodeficiency, including changes in T regulatory cells (T(regs)). We determined the pattern of expression forkhead box P3 (FoxP3), CD25, CD27 and CD127 showed that frequency CD4+ FoxP3+ was increased CLL patients (12% versus 8% controls). This increase seen only advanced disease, selective expansion FoxP3-expressing CD25(low) population, whereas number CD25(high) unchanged. reduced CD27, this phenotype also on all CD4 subsets patients, irrespective CD25 or FoxP3 expression. Incubation primary tumours led to a sixfold CD25- cells. Patients undergoing treatment fludarabine demonstrated transient percentage cells, but normal levels post-treatment. work demonstrates exhibit systemic cell dysregulation leading accumulation appears be driven by interaction malignant understanding mechanisms are involved could provide novel avenues for treatment.

参考文章(53)
M Lotz, E Ranheim, T J Kipps, Transforming growth factor beta as endogenous growth inhibitor of chronic lymphocytic leukemia B cells. Journal of Experimental Medicine. ,vol. 179, pp. 999- 1004 ,(1994) , 10.1084/JEM.179.3.999
Ethan M. Shevach, Elisabeth Suri-Payer, Angela M. Thornton, Anna Z. Amar, CD4+CD25+ T Cells Inhibit Both the Induction and Effector Function of Autoreactive T Cells and Represent a Unique Lineage of Immunoregulatory Cells Journal of Immunology. ,vol. 160, pp. 1212- 1218 ,(1998)
Tyler J Curiel, George Coukos, Linhua Zou, Xavier Alvarez, Pui Cheng, Peter Mottram, Melina Evdemon-Hogan, Jose R Conejo-Garcia, Lin Zhang, Matthew Burow, Yun Zhu, Shuang Wei, Ilona Kryczek, Ben Daniel, Alan Gordon, Leann Myers, Andrew Lackner, Mary L Disis, Keith L Knutson, Lieping Chen, Weiping Zou, Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nature Medicine. ,vol. 10, pp. 942- 949 ,(2004) , 10.1038/NM1093
Vissia Viglietta, Clare Baecher-Allan, Howard L. Weiner, David A. Hafler, Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis Journal of Experimental Medicine. ,vol. 199, pp. 971- 979 ,(2004) , 10.1084/JEM.20031579
Peter Hersey, Christian P Gray, Paolo Arosio, Association of Increased Levels of Heavy-Chain Ferritin with Increased CD4+ CD25+ Regulatory T-Cell Levels in Patients with Melanoma Clinical Cancer Research. ,vol. 9, pp. 2551- 2559 ,(2003)
Weihong Liu, Amy L. Putnam, Zhou Xu-yu, Gregory L. Szot, Michael R. Lee, Shirley Zhu, Peter A. Gottlieb, Philipp Kapranov, Thomas R. Gingeras, Barbara Fazekas de St. Groth, Carol Clayberger, David M. Soper, Steven F. Ziegler, Jeffrey A. Bluestone, CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells Journal of Experimental Medicine. ,vol. 203, pp. 1701- 1711 ,(2006) , 10.1084/JEM.20060772
Nabila Seddiki, Brigitte Santner-Nanan, Jeff Martinson, John Zaunders, Sarah Sasson, Alan Landay, Michael Solomon, Warwick Selby, Stephen I. Alexander, Ralph Nanan, Anthony Kelleher, Barbara Fazekas de St. Groth, Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells Journal of Experimental Medicine. ,vol. 203, pp. 1693- 1700 ,(2006) , 10.1084/JEM.20060468
Federico Caligaris-Cappio, Terry J. Hamblin, B-Cell Chronic Lymphocytic Leukemia: A Bird of a Different Feather Journal of Clinical Oncology. ,vol. 17, pp. 399- 399 ,(1999) , 10.1200/JCO.1999.17.1.399
Fritz Melchers, Immunity and Autoimmunity Karger Publishers. ,vol. 46, pp. 17- 25 ,(1991) , 10.1159/000419959